TeraRecon awarded 2 AI patents for medical imaging technology

Michael Walter | | Health Exec | Precision Medicine

TeraRecon announced Monday, March 2, that its AI solutions have been awarded two technology patents from the U.S. Patent and Trademark Office.

The first patent, “System and Method for Medical Image Interpretation,” covers the company’s image analysis engine, including the machine learning-powered capabilities that help the technology evolve based on user modifications.

The second, “Medical Image Identification and Interpretation,” covers similar ground, also emphasizing AI that uses prior imaging findings to reach its conclusions.

“Prioritizing physician control over AI findings is key to garnering trust and achieving wide-spread clinical adoption,” Jeff Sorenson, TeraRecon CEO, said in a prepared statement. “These platform patents cover a wide and important range of image interpretation use cases, validating TeraRecon as the standard-bearer for interactive AI-driven radiology interpretation technology.” 

Additional information on these patents, including full PDFs, is available on the company’s website.

Michael Walter
Michael Walter, Managing Editor

Michael has more than 18 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.

Related Content

Pitching the business case for 3D printing labs in radiology
FDA issues first-ever clearance for OTC oximeter
Augmented reality company secures $15M in funding from Cleveland Clinic, Mayo, GE Healthcare and more
Merck to acquire Prometheus Biosciences for $10.8B
Johnson & Johnson scraps RSV vaccine after trial
Intermountain Health launches new biotech company

Around the web

Cardiovascular Business
Payment cuts and beyond: Key takeaways for cardiologists from the 2025 Medicare Physician Fee Schedule

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

AI in Healthcare
A modest proposal to rally AI regulators around a simple game plan

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”

Cardiovascular Business
FDA commissioner urges clinicians to join fight against medical misinformation

FDA Commissioner Robert Califf, MD, said the clinical community needs to combat health misinformation at a grassroots level. He warned that patients are immersed in a "sea of misinformation without a compass."